Synthesis and evaluation of pyridinium polyoxometalates as anti-HIV-1 agents

被引:25
作者
Wang, Shunyi [1 ]
Sun, Wuji [1 ]
Hu, Qin [1 ]
Yan, Hong [1 ]
Zeng, Yi [1 ]
机构
[1] Beijing Univ Technol, Coll Life Sci & Bioengn, 100 Pingleyuan, Beijing 100124, Peoples R China
基金
中国国家自然科学基金;
关键词
Pyridinium polyoxometalates; Human immunodeficiency virus; Synthesis; TZM-bl assay; HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX-VIRUS; IN-VITRO; HETEROPOLYOXOTUNGSTATE PM-19; PROTEASE INHIBITION; ANTIVIRAL ACTIVITY; MECHANISM; TYPE-1; HPA-23; SPECIFICITY;
D O I
10.1016/j.bmcl.2017.04.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The unique properties of polyoxometalates, such as molecular polarity, redox potential, surface charge distribution, shape and acidity, influence their response of recognition to targeted biological macromolecules. By using PM-19 (K7PTi2W10O40) as a lead-compound, a series of novel pyridinium polyoxometalates (A(7)PTi(2)W(10)O(40)), which hadn't been reported in literatures, were designed and synthesized. The evaluation was conducted using the single-cycle pseudovirus infection assay (TZM-bl assay), CCK8 method was used for determining the cytotoxicity. The results indicated that the designed pyridinium polyoxometalates had a lower toxicity to TZM-bl cells, and showed higher inhibitory activity against HIV 1 virus. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:2357 / 2359
页数:3
相关论文
共 33 条
  • [1] Synthesis, Structure, and Antibacterial Activity of a Thallium(III)-Containing Polyoxometalate, [Tl2{B-β-SiW8O30(OH)}2]12-
    Ayass, Wassim W.
    Fodor, Tamas
    Lin, Zhengguo
    Smith, Rachelle M.
    Xing, Xiaolin
    Abdallah, Khaled
    Toth, Imre
    Zekany, Laszlo
    Pascual-Borras, Magda
    Rodriguez-Fortea, Antonio
    Poblet, Josep M.
    Fan, Linyuan
    Cao, Jie
    Keita, Bineta
    Ullrich, Matthias S.
    Kortz, Ulrich
    [J]. INORGANIC CHEMISTRY, 2016, 55 (20) : 10118 - 10121
  • [2] TOXICITY OF HPA-23 (AMMONIUM-21-TUNGSTO-9-ANTIMONIATE) FOR NORMAL HUMAN MYELOID PROGENITOR CELLS (GM-CFU) INVITRO
    AYMARD, JP
    FERRY, R
    JANOT, C
    SCHOONEMAN, F
    LEGRAS, B
    MAY, T
    STREIFF, F
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1989, 43 (06) : 451 - 454
  • [3] LACK OF HPA-23 ANTIVIRAL ACTIVITY IN HIV-INFECTED PATIENTS WITHOUT AIDS
    BURGARD, M
    SANSONETTI, P
    VITTECOQ, D
    DESCAMPS, P
    GUETARD, D
    HERSON, S
    ROZENBAUM, W
    ROUZIOUX, C
    [J]. AIDS, 1989, 3 (10) : 665 - 668
  • [4] Design and fabrication of memory devices based on nanoscale polyoxometalate clusters
    Busche, Christoph
    Vila-Nadal, Laia
    Yan, Jun
    Miras, Haralampos N.
    Long, De-Liang
    Georgiev, Vihar P.
    Asenov, Asen
    Pedersen, Rasmus H.
    Gadegaard, Nikolaj
    Mirza, Muhammad M.
    Paul, Douglas J.
    Poblet, Josep M.
    Cronin, Leroy
    [J]. NATURE, 2014, 515 (7528) : 545 - 549
  • [5] Hydrothermal syntheses of some derivatives of tetraazatriphenylene
    Che, Guangbo
    Li, Wenlian
    Kong, Zhiguo
    Su, Zisheng
    Chu, Bei
    Li, Bin
    Zhang, Zhiqiang
    Hu, Zhizhi
    Chi, Haijun
    [J]. SYNTHETIC COMMUNICATIONS, 2006, 36 (17) : 2519 - 2524
  • [6] Current status and prospects of HIV treatment
    Cihlar, Tomas
    Fordyce, Marshall
    [J]. CURRENT OPINION IN VIROLOGY, 2016, 18 : 50 - 56
  • [7] Prevention of the interaction between HVEM, herpes virus entry mediator, and gD, HSV envelope protein, by a Keggin polyoxotungstate, PM-19
    Dan, K
    Yamase, T
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (04) : 169 - 173
  • [8] Mechanism of the protective effect of heteropolyoxotungstate against herpes simplex virus type 2
    Dan, K
    Miyashita, K
    Seto, Y
    Fujita, H
    Yamase, T
    [J]. PHARMACOLOGY, 2003, 67 (02) : 83 - 89
  • [9] The memory effect of heteropolyoxotungstate (PM-19) pretreatment on infection by herpes simplex virus at the penetration stage
    Dan, K
    Miyashita, K
    Seto, Y
    Fujita, H
    Yamase, T
    [J]. PHARMACOLOGICAL RESEARCH, 2002, 46 (04) : 357 - 362
  • [10] Delina Barats-Damatov, INORG CHEM, V1779